Published in Blood Weekly, May 18th, 2000
The MATS was created by K. Fukunaga and colleagues, who employed plasmapheresis technology and a unique polyethylene hollow fiber membrane in the system's design. The researchers performed a study to assess how well the experimental prototype, MATS-I, operated.
"The results of this study showed that the MATS-I could concentrate diluted blood at 10% of the initial hematocrit concentration (HCTi) into over 40% after passing through the system at a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.